SA
CTXR icon

Sanctuary Advisors’s Citius Pharmaceuticals CTXR Stock Holding History

Sanctuary Advisors’s Portfolio CTXR Stock Details CTXR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.14K Buy
+11,810
New +$7.99K ﹤0.01% 2830
2024
Q4 		– Sell
-500
Closed -$1.67K – 2411
2024
Q3 		$1.67K Buy
+500
New +$8.41K ﹤0.01% 2364

Other funds holding CTXR

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
MFS
Miller Financial Services Marshall, Michigan $124M AUM 17.62% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
AAG
Asset Advisory Group Kinnelon, New Jersey $229M AUM

Sanctuary Advisors's CTXR Position: Q2 2026 in Review

Sanctuary Advisors opened a new position in Citius Pharmaceuticals (CTXR) in Q2 2026: 11,810 shares worth $7.14K. The stake represents ﹤0.01% of the portfolio and ranks #2830 among its holdings. This is a return to the name: Sanctuary Advisors previously reported a position in CTXR as recently as Q3 2024.

Sanctuary Advisors first reported a position in CTXR in Q3 2024 and has held it in 2 quarters since. 43 funds tracked by Wall St. Rank hold CTXR as of Q2 2026.

  • Sanctuary Advisors held 11,810 shares of Citius Pharmaceuticals worth $7.14K as of Q2 2026.
  • Citius Pharmaceuticals was a new Sanctuary Advisors position in Q2 2026.
  • Citius Pharmaceuticals made up ﹤0.01% of Sanctuary Advisors's portfolio in Q2 2026, its #2830 holding.
  • Sanctuary Advisors first reported a position in Citius Pharmaceuticals in Q3 2024 and has held it in 2 quarters since.
  • 43 funds tracked by Wall St. Rank held Citius Pharmaceuticals as of Q2 2026.

Based on Sanctuary Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.